- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - homo-trimer
 - Ligands
 - 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 - 16 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-BMA.4: 3 residues within 4Å:- Chain A: N.319, E.320, N.321
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.6: 2 residues within 4Å:- Chain A: V.1172, N.1173
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.8: 5 residues within 4Å:- Chain A: N.370, T.372, Q.619, T.620, L.621
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.10: 5 residues within 4Å:- Chain A: N.840, F.841, S.842, Q.843, I.970
 
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.842
 
NAG-NAG-BMA.11: 4 residues within 4Å:- Chain A: A.745, S.750, N.1113
 - Chain B: Q.934
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 4 residues within 4Å:- Chain A: N.748, N.749, G.1170
 - Chain B: D.835
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.15: 3 residues within 4Å:- Chain A: K.597
 - Chain B: E.320, N.321
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.17: 3 residues within 4Å:- Chain B: N.756, T.758, L.961
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 4 residues within 4Å:- Chain B: N.1137, T.1139, H.1140, F.1142
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.21: 2 residues within 4Å:- Chain B: V.1172, N.1173
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 6 residues within 4Å:- Chain B: F.377, G.378, F.381, N.382, D.403, V.406
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.26: 4 residues within 4Å:- Chain C: T.147, N.273, I.274, T.275
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 4 residues within 4Å:- Chain B: K.597
 - Chain C: N.319, E.320, N.321
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.29: 6 residues within 4Å:- Chain C: N.756, T.758, L.961, N.964, Q.965, Q.1110
 
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.961
 
NAG-NAG-BMA.30: 3 residues within 4Å:- Chain C: N.840, S.842, Q.843
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.32: 4 residues within 4Å:- Chain C: N.1137, T.1139, H.1140, F.1142
 
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN- NAG- FUC: alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-FUC.20: 5 residues within 4Å:- Chain B: A.745, E.1111, K.1112, N.1113
 - Chain C: Q.934
 
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:N.1113
 
NAG-NAG-FUC.31: 2 residues within 4Å:- Chain A: Q.934
 - Chain C: N.1113
 
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.934, A:Q.934
 
- 1 x NAG- NAG- BMA- MAN- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
 NAG.34: 7 residues within 4Å:- Chain A: S.151, K.152, T.153, E.171, N.203, N.204
 - Ligands: NAG.37
 
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: T.346, T.641, N.642
 
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: F.682, H.694, N.696
 
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Ligands: NAG.34
 
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain B: Y.67, N.69, F.98, S.99, N.100
 
Ligand excluded by PLIPNAG.39: 7 residues within 4Å:- Chain B: K.186, N.187, N.188, S.190, M.192, S.295, G.296
 
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain B: G.271, I.272, N.273
 
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: N.370, Q.619
 
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain B: E.348, G.640, N.642, T.643
 
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: H.694, V.695, N.696
 
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain A: R.396
 - Chain B: N.204, C.205, T.206
 
Ligand excluded by PLIPNAG.45: 7 residues within 4Å:- Chain B: V.159, N.161, T.163, N.164, V.166, F.196, Y.199
 
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: Y.67, N.100
 
Ligand excluded by PLIPNAG.47: 5 residues within 4Å:- Chain C: Y.183, N.188, S.190, S.194, E.195
 
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: N.370, T.372, Q.619, T.620
 
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: H.694, N.696
 
Ligand excluded by PLIPNAG.50: 13 residues within 4Å:- Chain C: E.135, N.138, I.139, I.140, R.141, N.160, N.161, W.191, M.192, E.193, L.218, R.229, A.282
 
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.642
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Singh, S. et al., Cryo-EM structure of SARS CoV-2 full-length spike with Lys1269Ala and His1271Ala substitutions in the coatomer binding motif, 1RBD-up conformation. To Be Published
 - Release Date
 - 2025-04-16
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - homo-trimer
 - Ligands
 - 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 - 16 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 1 x NAG- NAG- BMA- MAN- NAG- FUC: alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 1 x NAG- NAG- BMA- MAN- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Singh, S. et al., Cryo-EM structure of SARS CoV-2 full-length spike with Lys1269Ala and His1271Ala substitutions in the coatomer binding motif, 1RBD-up conformation. To Be Published
 - Release Date
 - 2025-04-16
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C